A House committee has requested a briefing from Merck on the June 27 NotPetya malware attack that has impeded manufacturing operations, and on the pharmaceutical company's subsequent remediation efforts. Meanwhile, a pharmaceutical industry group is bringing experts together to brainstorm on cyber security best practices.
Merck & Co. Inc.'s recovery effort from a recent cyberattack now includes another high-profile item on the to-do list: responding to a congressional inquiry on the damage to its manufacturing operations.
The House Energy and Commerce Committee has asked Merck for a briefing by Oct